Prioritizing drugs for future clinical pharmacogenomics studies in Saudi Arabia: a generalizable multi-criteria framework
{{output}}
Aims: Despite over 400 high-evidence drug-gene associations in pharmacogenomic (PGx) guidelines and drug labels, prioritizing drugs for clinical PGx research remains challenging when local outcome data are limited. In Saudi Arabi... ...
